Attached files

file filename
EX-10.22 - FORM OF STOCK OPTION AGREEMENT - Endo International plcex1022formofstockoptionagre.htm
EX-32.1 - CEO SECTION 906 CERTIFICATION - Endo International plcex3213312016ceo906cert.htm
EX-10.5.2 - NORAMCO 4TH AMENDMENT TO SUPPLY AGREEMENT - Endo International plcex1052noramco4thamendmentto.htm
EX-10.24 - FORM OF PERFORMANCE AWARD AGREEMENT - Endo International plcex1024formofperformanceawar.htm
EX-10.35 - FORM OF INDEMNIFICATION AGREEMENT - Endo International plcex1035endointernationalplc.htm
EX-31.1 - CEO SECTION 302 CERTIFICATION - Endo International plcex3113312016ceo302cert.htm
EX-10.28.1 - NOVARTIS SANDOZ ENDO LETTER AGREEMENT - Endo International plcex10281novartissandozendo.htm
EX-31.2 - CFO SECTION 302 CERTIFICATION - Endo International plcex3123312016cfo302cert.htm
EX-10.23 - FORM OF STOCK AWARD AGREEMENT - Endo International plcex1023formofstockawardagree.htm
EX-10.5.1 - NORAMCO 3RD AMENDMENT TO SUPPLY AGREEMENT - Endo International plcex1051noramco3rdamendmentto.htm
10-Q - 10-Q - Endo International plcendp-3312016x10q.htm
EX-10.5.3 - NORAMCO 5TH AMENDMENT TO SUPPLY AGREEMENT - Endo International plcex1053noramco5thamendmentt.htm
Exhibit 32.2

CERTIFICATION OF CHIEF FINANCIAL OFFICER
PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
I, Suketu P. Upadhyay, as Chief Financial Officer of Endo International plc (the Company), hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
(1) The Quarterly Report on Form 10-Q of the Company for the quarterly period ended March 31, 2016 (the Report) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m); and
(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
 
 
 
 
 
 
 
/S/ SUKETU P. UPADHYAY
Name:
 
Suketu P. Upadhyay
Title:
 
Executive Vice President, Chief Financial Officer
(Principal Financial Officer)
Date: May 6, 2016
A signed original of this written statement required by Section 906 has been provided to, and will be retained by, Endo International plc and furnished to the Securities and Exchange Commission or its staff upon request.